Page last updated: 2024-09-03

imatinib mesylate and Hemorrhage, Vitreous

imatinib mesylate has been researched along with Hemorrhage, Vitreous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Afacan Öztürk, HB; Albayrak, M; Maral, S; Reis Aras, M; Sağlam, B; Tığlıoğlu, M; Tığlıoğlu, P; Yılmaz, F	1

Other Studies

1 other study(ies) available for imatinib mesylate and Hemorrhage, Vitreous

Article	Year
Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:3 Topics: Antineoplastic Agents; Benzamides; Drug-Related Side Effects and Adverse Reactions; Edema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Vitreous Hemorrhage	2022

Article

Year

Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:3

Topics: Antineoplastic Agents; Benzamides; Drug-Related Side Effects and Adverse Reactions; Edema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Vitreous Hemorrhage

2022